Médecins Sans Frontières urges governments to step up the use of newer TB drugs.

The Progress Report shows need for huge efforts and scale-up to reach 90-(90)-90 TB targets.

25 September marks the first ever World Lung Day, a day of advocacy coordinated by the Forum of International Respiratory Societies, for all those affected by, and working to end, respiratory disease.

Reframing risk and accountability for action to zero TB is a symposium organized by Treatment Action Group, Advanced Access & Delivery, Partners in Health, Harvard Medical School, and the Stop TB Partnership.

WHO report highlights TB as a top priority for research and development of new antibiotics.

TB advocates urge the Indian government to develop a concrete plan for introducing delamanid.

The guide provides important messaging and strategies to support advocacy and activism for access to LAM testing, the only point-of-care TB diagnostic test overall that has a proven impact on reducing TB deaths in people with HIV.

In collaboration wih the International Treatment Preparedness Coalition, Russia.

Тhe Global TB Community Advisory Board (TB CAB) releases a position paper regarding the optimal design for future evaluation of regimens for the treatment of extensively drug-resistant TB (XDR-TB).

TB advocates urge the Kenyan Division of Leprosy, Tuberculosis and Lung Disease (DLTLD) to introduce a new, simple, and rapid TB test, TB LAM, which detects TB antigens in urine, and is an important tool for detecting TB in certain populations living with HIV.